Ross has over 30 years of extensive drug development experience in the biopharmaceutical industry across clinical operations, program management, data management, regulatory affairs and medical affairs. He joins CHARM from H3 Biomedicine, where he worked as Deputy President, holding leadership responsibilities over all business operations and leading the exclusive out-license of H3 Biomedicine’s splicing modulator to Roivant Sciences. Ross previously served in senior roles at Beigene Pharmaceuticals, AMAG Pharmaceuticals and ARIAD Pharmaceuticals. He holds an MBA in Healthcare management.
